n if e a m ox T on ients Pat r e c a n C ast e r B Follow-Up Recommendations Breast Cancer Patients on Aromatase Inhibitors (AIs) ▪ Follow-up begins at the end of primary therapy ...

Follow-Up Recommendations Breast Cancer Patients (not receiving hormonal therapy) Follow-up begins at the end of primary therapy (surgery / chemotherapy / radiation) Years 1 – 3 Years 4 – 5 Years 6+ Primary Care Visits ...

Follow-Up Recommendations Breast Cancer Patients on Tamoxifen ▪ Follow-up begins at the end of primary therapy (surgery / chemotherapy / radiation) ▪ Tamoxifen 20mg daily for 5-10 years based on oncologist assessment. ...

Zoledronic Acid will be used as part of anticancer treatment for selected early stage breast cancer patients (postmenopausal, pre-menopausal requiring ovarian suppression) to prevent breast cancer from coming back or reoccuring elsewhere in ...

Date: Re: Follow-Up Care for Dear : Your patient has completed treatment for cervical cancer and has no evidence of recurrent disease. ...

Date: Re: Follow-Up Care for Dear : Your patient has completed treatment for colorectal cancer and has no evidence of recurrent disease. ...

Date: Re: Follow-Up Care for Dear : Family Physician / Nurse Practitioner / Surgeon Your patient has completed treatment for colorectal cancer and has no evidence of recurrent disease. ...

Date: Re: Follow-Up Care for Dear The above patient has completed treatment for _____________________________________________ leukemia and has no evidence of recurrent disease. ...

Date: Re: Follow-Up Care for Dear : The above patient has completed treatment for _______________________ lymphoma and has no evidence of recurrent disease. ...

Date: Re: Follow-Up Care for Dear : The above patient has completed treatment for _______________________ lymphoma and has no evidence of recurrent disease. ...